SCHEMBL25640474

SCHEMBL25640474

CC(C)c1ccccc1[C@@H]1CN(Cc2ccncc2)CCN1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.41
CCR2 P41597 1/20 0.39
GSK3B P49841 6/20 0.38
HPGD P15428 1/20 0.37
LMNA P02545 1/20 0.36
LTA4H P09960 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
KCNJ1 P48048 3/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2B Q13224 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25640475 0.88 CHRNB2 (0.44) LMNAALDH1A1MAPK1KMT2ATRPV6
SCHEMBL25479105 0.87 JAK2 (0.35) GSK3BLTA4HKCNJ1GRIN1GRIN2B
SCHEMBL25640513 0.87 TACR1 (0.40) LMNALTA4HALDH1A1GRIN1GRIN2B
SCHEMBL25478882 0.87 LTA4H (0.39) LTA4HCYP1A2CYP3A4KCNJ1ALDH1A1
SCHEMBL25640507 0.87 HRH3 (0.40) CCR2LTA4HCYP1A2CYP3A4MEN1
SCHEMBL25640471 0.86 TACR1 (0.44) CYP3A4
SCHEMBL25640511 0.85 MLNR (0.44) LMNAALDH1A1SIGMAR1KDM4E
SCHEMBL23943756 0.84 SIGMAR1 (0.47) LTA4HMEN1KMT2ASIGMAR1
SCHEMBL25190429 0.84 SIGMAR1 (0.47) LTA4HMEN1KMT2ASIGMAR1
SCHEMBL25640515 0.84 ALDH1A1 (0.42) LTA4HALDH1A1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104043-A1 ANTI-APOPTOTIC PROTEIN BCL-2 INHIBITOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF 杭州和正医药有限公司 2023-06-15 WO disclosed